Vitamin B6, an essential nutrient taken as a dietary supplement for health and longevity, helps enzymes handle protein, brain chemical messengers and blood formation. Firmest benefits are narrow: easing early-pregnancy nausea, easing premenstrual symptoms with less certainty, and correcting low levels. Longevity benefits rest mainly on population studies or trials adding folic acid and B12. Sustained high intake can injure sensory nerves; intake near dietary needs shows the clearest balance. (Full Review)

Protocol

Maintenance within an upper limit

≤12 mg/day total intake

European (EFSA) limit; 100 mg/day under the U.S. limit; food plus a multivitamin usually stays below both

Condition-specific doses

25 mg three times daily

For pregnancy nausea; up to 100 mg/day for premenstrual symptoms; both short-term

Form

Pyridoxine hydrochloride

Used in nearly all trials; the active form P5P bypasses liver activation, but no human trial shows better outcomes or lower neuropathy risk

Time to effect

Pregnancy nausea

Within 3 days

Shown for ordinary pregnancy nausea, not severe pregnancy vomiting needing hospital care

Premenstrual effects

2–3 cycles

Period over which effects are judged

Blood levels

About 10 days

Plateau with daily intravenous dosing

Benefits

High: Relief of nausea and vomiting of pregnancy; premenstrual symptom relief

Medium: Correction of low B6 status; reduction of tardive dyskinesia; relief of antipsychotic-induced akathisia; lower antipsychotic-induced prolactin; reduced dental decay in pregnancy; migraine-with-aura prevention; restless legs symptom relief

Low: Stroke prevention within a B-vitamin combination; slower brain atrophy in mild cognitive impairment; lower coronary heart disease and mortality; lower cancer risk; anxiety and depressive symptoms; relief of levetiracetam-related behavioral side effects; prevention of chemotherapy hand-foot syndrome; adjunct relief of acute low back pain; control of inherited B6-dependent disorders

Speculative: Lower systemic inflammation; reduced advanced glycation

Contraindications

History of sensitivity (allergic-type reaction) to pyridoxine

Existing or unexplained peripheral neuropathy, for total intake above the 12 mg/day upper limit (inferred; no study has tested B6 in this group)

Parkinson's disease taking levodopa without carbidopa or benserazide, for supplements providing more than 5 mg pyridoxine daily

Diabetic kidney disease, for high-dose combinations (25 mg B6, 2.5 mg folic acid, 1 mg B12 daily)

Within 7 days of an acute myocardial infarction (heart attack), for 40 mg B6 combined with folic acid and B12

Adults, including pregnant and breastfeeding women, for total intake above the 12 mg/day upper limit without medical supervision

Postmenopausal women at high fracture risk, for total intakes of 35 mg/day or more

Key Interactions

Carbidopa–levodopa (Parkinson's drug): depletes vitamin B6; deficiency-associated seizures reported above 1,000 mg levodopa daily

Anti-seizure drugs (phenytoin, phenobarbital): high-dose pyridoxine lowered serum levels of both drugs

Isoniazid (tuberculosis drug): depletes B6 and causes peripheral neuropathy

Oral contraceptives (ethinyl estradiol combinations): most users had low plasma PLP

Hydralazine (blood pressure drug): has caused peripheral neuropathy from pyridoxine deficiency

Penicillamine (copper-binding drug): increased pyridoxine requirements

Theophylline (asthma drug): lowered plasma PLP

Cisplatin with hexamethylmelamine (altretamine) chemotherapy: pyridoxine (300 mg/m² daily) shortened tumor response duration

Over-the-counter B6-containing products (multivitamins, B-complexes, magnesium–B6): additive intake above the upper limit risks sensory neuropathy

Theoretical (inferred from mechanism)

Neurotoxic drugs (metronidazole, paclitaxel): additive sensory nerve injury

Photosensitizing drugs (hydrochlorothiazide): possible additive skin photosensitivity

Risk & Side Effects

Medium: Sensory peripheral neuropathy; higher hip fracture risk; lower birthweight

Low: Cardiovascular and kidney harm in high-risk patients; lung cancer in men with long-term high-dose use; adverse pregnancy outcomes with high-dose use; dependence and withdrawal after high doses; somnolence; low serum folate

Monitoring

Marker	Target	Why
Plasma PLP (pyridoxal 5'-phosphate)	≥30 nmol/L (sufficiency cutoff; <20 nmol/L deficient)	Status; also a safety check when markedly high
Homocysteine	<9 µmol/L (Peter Attia's target)	Expected to change, mainly with folate and B12
Vibration sense and reflexes (clinical exam)	No established target; track change from own baseline	Safety check: new loss stops use
eGFR	≥60 mL/min/1.73 m²; track change from own baseline	Safety check in diabetes or kidney disease

Cadence: Baseline before starting supplemental B6 above dietary levels; PLP and homocysteine at 8–12 weeks, then every 6–12 months while supplemental intake exceeds 10 mg/day; sensation and balance every 3 months on high doses; PLP at once if tingling, burning or numbness appears

Qualitative Assessment

Tingling, burning or numbness in hands or feet, or new unsteadiness (stop signal)
Target symptom change (nausea, premenstrual mood, anxiety)
Dream vividness and sleep quality
Energy and mood across the menstrual cycle, where relevant

Vitamin B6 for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment